Intimal Media Thickness Karotis Pada Penderita Gagal Jantung Kronik
Abstract
Pada studi kohort resiko kematian penderita gagal ginjal kronik (GGK) lebih berhubungan dengan faktor resiko tradisional seperti hipertensi dan diabetes mellitus dibanding dengan faktor resiko yang lebih baru seperti C-reactive protein (CRP) dan fibrinogen. Faktor resiko konvensional didasarkan pada faktor-faktor yang biasa digunakan dalam stratifikasi resiko penyakit kardiovaskular seperti pada kohort Framingham, yaitu: usia tua, laki-laki, hipertensi, diabetes, merokok, dislipidemia dan LVH. Faktor resiko non-konvensioanl tidak didasari pada faktor aterosklerosis pada umumnya, namun faktor resiko yang dapat meningkat pada saat menurunnya fungsi ginjal, seperti inflamasi atau hal yang khusus yang berkaitan dengan pasien GGK seperti anemia.Downloads
Download data is not yet available.
References
Wahidji V, Sunu I, Kusmana D. Hubungan intimal media thickness karotis dengan faktor resiko kardiovaskular pada pasien gagal ginjal kronik pra-dialisis. J Kardiol Indones. 2009;30:15-23
Susan J. Traditional risk factors still predict most of CVD mortality risk in chronic kidney disease. HeartWire, 2005
Shlipak MG, Fried LF, Cushman M, dkk. Cardiovascular mortality risk in chrinic kidney disease: Comparison of traditional and novel risk factors. JAMA. 2005;293:1737-45
Menon V, Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005;68:1413-8.
McCullough PA, Li S, Jurkovitz CT, dkk. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008;156:277-83.
Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimb O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3:505-21.
Baber U, Toto RD, de Lemos JA. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. Am Heart J. 2007;153:471-7.
Lahoz C, Mostaza JM, Mantilla MT, dkk. Achievement of Therapeutic goals and utilization of Evidence-based cardiovascular terapies in coronary heart disease patients with chronic kidney disease. Am J Cardiol. 2008;101:1098-102.
Mitja L. Cardiovascular risk in chronic kidney disease. International Federation of Clinical Chemistry and Laboratory Medicine. Annual Report, 2008.
Susan J
Shlipak MG, Fried LF, Cushman M, dkk. Cardiovascular mortality risk in chrinic kidney disease: Comparison of traditional and novel risk factors. JAMA. 2005;293:1737-45
Menon V, Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005;68:1413-8.
McCullough PA, Li S, Jurkovitz CT, dkk. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008;156:277-83.
Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimb O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3:505-21.
Baber U, Toto RD, de Lemos JA. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. Am Heart J. 2007;153:471-7.
Lahoz C, Mostaza JM, Mantilla MT, dkk. Achievement of Therapeutic goals and utilization of Evidence-based cardiovascular terapies in coronary heart disease patients with chronic kidney disease. Am J Cardiol. 2008;101:1098-102.
Mitja L. Cardiovascular risk in chronic kidney disease. International Federation of Clinical Chemistry and Laboratory Medicine. Annual Report, 2008.
Views & Downloads
Abstract views: 1974
PDF (Bahasa Indonesia) downloads: 1584
PDF (Bahasa Indonesia) downloads: 1584
How to Cite
Kasiman, S. (1). Intimal Media Thickness Karotis Pada Penderita Gagal Jantung Kronik. Indonesian Journal of Cardiology, 30(3), 114-6. https://doi.org/10.30701/ijc.v30i3.279
Section
Comments
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).